New Delhi: Atul Sobti, the CEO and MD of Ranbaxy Laboratories Ltd, India’s largest drugmaker by revenue, is likely to step down from his posts at the company on Thursday. Sobti will be moving out of Ranbaxy.
“He was always the temporary head of Ranbaxy. When Malvinder (Mohan Singh) left a year ago, Daiichi had to find someone quickly and Sobti being the senior most was asked to take charge. Now someone with more experience in this industry will take over,” said a person closely related to the development.
Sobti had joined Ranbaxy in 2007 leaving his position as the head of marketing at Hero Honda. He was made CEO when in May last year, Singh stepped out of Ranbaxy.
A Ranbaxy spokesperson said there was no such information available.